Segall Bryant & Hamill’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2M | Sell |
16,611
-19
| -0.1% | -$2.19K | 0.03% | 423 |
|
|
2025
Q4 | $1.75M | Sell |
16,630
-79
| -0.5% | -$7.42K | 0.02% | 452 |
|
|
2025
Q3 | $1.4M | Sell |
16,709
-2,530
| -13% | -$208K | 0.02% | 469 |
|
|
2025
Q2 | $1.52M | Hold |
19,239
| – | – | 0.02% | 468 |
|
|
2025
Q1 | $1.73M | Sell |
19,239
-176
| -0.9% | -$16.4K | 0.03% | 446 |
|
|
2024
Q4 | $1.93M | Sell |
19,415
-1,507
| -7% | -$155K | 0.03% | 446 |
|
|
2024
Q3 | $2.38M | Buy |
+20,922
| New | +$2.49M | 0.03% | 416 |
|
|
2023
Q4 | – | Sell |
-131,859
| Closed | -$13.6M | – | 421 |
|
|
2023
Q3 | $13.6M | Sell |
131,859
-165
| -0.1% | -$17.8K | 0.16% | 171 |
|
|
2023
Q2 | $15.2M | Sell |
132,024
-3,493
| -3% | -$397K | 0.16% | 168 |
|
|
2023
Q1 | $14.4M | Sell |
135,517
-919
| -0.7% | -$99.2K | 0.16% | 179 |
|
|
2022
Q4 | $15.1M | Sell |
136,436
-470
| -0.3% | -$48K | 0.17% | 167 |
|
|
2022
Q3 | $11.8M | Sell |
136,906
-1,265
| -0.9% | -$113K | 0.14% | 183 |
|
|
2022
Q2 | $12.6M | Sell |
138,171
-1,837
| -1% | -$163K | 0.14% | 170 |
|
|
2022
Q1 | $11.5M | Sell |
140,008
-5,427
| -4% | -$428K | 0.11% | 199 |
|
|
2021
Q4 | $11.1M | Buy |
145,435
+807
| +0.6% | +$64.3K | 0.1% | 198 |
|
|
2021
Q3 | $10.9M | Buy |
144,628
+13,543
| +10% | +$1.03M | 0.1% | 205 |
|
|
2021
Q2 | $10.2M | Sell |
131,085
-10,634
| -8% | -$791K | 0.1% | 209 |
|
|
2021
Q1 | $10.4M | Sell |
141,719
-4,973
| -3% | -$367K | 0.1% | 210 |
|
|
2020
Q4 | $11.4M | Sell |
146,692
-464
| -0.3% | -$35.5K | 0.13% | 180 |
|
|
2020
Q3 | $11.6M | Sell |
147,156
-9,627
| -6% | -$754K | 0.16% | 144 |
|
|
2020
Q2 | $11.6M | Buy |
156,783
+8,328
| +6% | +$627K | 0.19% | 115 |
|
|
2020
Q1 | $10.9M | Sell |
148,455
-1,237
| -0.8% | -$97.2K | 0.22% | 102 |
|
|
2019
Q4 | $13M | Sell |
149,692
-4,335
| -3% | -$356K | 0.2% | 119 |
|
|
2019
Q3 | $12.4M | Sell |
154,027
-361
| -0.2% | -$28.9K | 0.19% | 138 |
|
|
2019
Q2 | $12.4M | Sell |
154,388
-385
| -0.2% | -$29.5K | 0.19% | 151 |
|
|
2019
Q1 | $12.3M | Sell |
154,773
-3,138
| -2% | -$235K | 0.19% | 144 |
|
|
2018
Q4 | $11.5M | Buy |
157,911
+77
| +0% | +$5.44K | 0.2% | 138 |
|
|
2018
Q3 | $10.7M | Sell |
157,834
-7,629
| -5% | -$486K | 0.16% | 183 |
|
|
2018
Q2 | $9.58M | Buy |
165,463
+41,359
| +33% | +$2.33M | 0.15% | 193 |
|
|
2018
Q1 | $6.45M | Buy |
124,104
+1,541
| +1% | +$83.2K | 0.15% | 158 |
|
|
2017
Q4 | $6.58M | Sell |
122,563
-9,450
| -7% | -$524K | 0.14% | 165 |
|
|
2017
Q3 | $8.07M | Sell |
132,013
-388
| -0.3% | -$23.5K | 0.19% | 130 |
|
|
2017
Q2 | $8.1M | Buy |
132,401
+1,321
| +1% | +$80.4K | 0.19% | 119 |
|
|
2017
Q1 | $7.95M | Buy |
131,080
+1,298
| +1% | +$78.7K | 0.19% | 122 |
|
|
2016
Q4 | $7.29M | Buy |
129,782
+2,428
| +2% | +$142K | 0.18% | 130 |
|
|
2016
Q3 | $7.58M | Sell |
127,354
-314
| -0.2% | -$18.4K | 0.19% | 119 |
|
|
2016
Q2 | $7.02M | Sell |
127,668
-2,977
| -2% | -$158K | 0.19% | 135 |
|
|
2016
Q1 | $6.6M | Buy |
130,645
+2,554
| +2% | +$125K | 0.16% | 163 |
|
|
2015
Q4 | $6.46M | Sell |
128,091
-463
| -0.4% | -$23.3K | 0.16% | 172 |
|
|
2015
Q3 | $6.06M | Buy |
128,554
+12,286
| +11% | +$653K | 0.15% | 178 |
|
|
2015
Q2 | $6.32M | Sell |
116,268
-2,425
| -2% | -$136K | 0.14% | 195 |
|
|
2015
Q1 | $6.51M | Buy |
118,693
+2,693
| +2% | +$152K | 0.15% | 188 |
|
|
2014
Q4 | $6.29M | Buy |
116,000
+211
| +0.2% | +$11.8K | 0.14% | 191 |
|
|
2014
Q3 | $6.55M | Sell |
115,789
-1,397
| -1% | -$78.4K | 0.15% | 175 |
|
|
2014
Q2 | $6.47M | Sell |
117,186
-14,770
| -11% | -$806K | 0.15% | 177 |
|
|
2014
Q1 | $7.15M | Sell |
131,956
-6,728
| -5% | -$348K | 0.17% | 168 |
|
|
2013
Q4 | $6.62M | Buy |
138,684
+2,391
| +2% | +$109K | 0.15% | 170 |
|
|
2013
Q3 | $6.19M | Buy |
136,293
+3,975
| +3% | +$181K | 0.15% | 176 |
|
|
2013
Q2 | $5.87M | Buy |
+132,318
| New | +$5.91M | 0.15% | 177 |
|
Other funds holding MRK
VCM
VPM
Segall Bryant & Hamill's MRK Position: Q1 2026 in Review
Segall Bryant & Hamill reduced its Merck (MRK) stake by 0.11% in Q1 2026, selling an estimated $2.19K and leaving 16,611 shares worth $2M. The position accounts for 0.03% of the portfolio, ranked #423.
Segall Bryant & Hamill first reported a position in MRK in Q2 2013 and has held it in 49 quarters since. The position peaked at $15.2M in Q2 2023. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Segall Bryant & Hamill held 16,611 shares of Merck worth $2M as of Q1 2026.
- Segall Bryant & Hamill sold 19 Merck shares in Q1 2026, an estimated $2.19K.
- Merck made up 0.03% of Segall Bryant & Hamill's portfolio in Q1 2026, its #423 holding.
- Segall Bryant & Hamill first reported a position in Merck in Q2 2013 and has held it in 49 quarters since.
- Segall Bryant & Hamill's Merck position peaked at $15.2M in Q2 2023.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.